Achieve Life Sciences (ACHV) Deferred Taxes (2015 - 2017)

Achieve Life Sciences (ACHV) has 3 years of Deferred Taxes data on file, last reported at -$2.9 million in Q3 2017.

• Quarterly Deferred Taxes fell 2036.5% year-over-year to -$2.9 million in Q3 2017, while the trailing twelve-month figure through Dec 2017 was -$3.2 million (down 530.56% YoY) and the FY2017 annual result came in at -$3.1 million, down 505.36% from the prior year.
• Deferred Taxes declined to -$2.9 million in Q3 2017, from -$124000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of -$118000.0 in Q1 2016 to a low of -$2.9 million in Q3 2017.
• A 3-year average of -$566000.0 and a median of -$127000.0 in 2016 frame the typical range for Deferred Taxes.
• Annual changes were most pronounced in 2016 — Deferred Taxes jumped 68.8% — and 2017, when it sank 2036.5%.
• Tracing ACHV's Deferred Taxes over 3 years: stood at -$407000.0 in 2015, then jumped by 68.8% to -$127000.0 in 2016, then tumbled by 2204.72% to -$2.9 million in 2017.
• The last three Deferred Taxes figures came in at -$2.9 million (Q3 2017), -$124000.0 (Q1 2017), and -$127000.0 (Q4 2016), per Business Quant data.